Although the different modes of tumour progression were not directly correlated with differences in survival, a significantly shorter overall survival for patients with high VEGF-C expression was noted, which supports a possible prognostic impact of VEGF-C mediated retroperitoneal metastases. Here, VEGFC is linked to neoplasm.